DEF 14A

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

August 31, 2011

Period of Report

October 18, 2011

Accession Number

0001144204-11-050822

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →